DE69301644D1 - 1-Alkoxy-naphtalen-2-carboxamid-Derivate mit hoher Affinität für das 5-HT1A Rezeptor von Serotonin - Google Patents

1-Alkoxy-naphtalen-2-carboxamid-Derivate mit hoher Affinität für das 5-HT1A Rezeptor von Serotonin

Info

Publication number
DE69301644D1
DE69301644D1 DE69301644T DE69301644T DE69301644D1 DE 69301644 D1 DE69301644 D1 DE 69301644D1 DE 69301644 T DE69301644 T DE 69301644T DE 69301644 T DE69301644 T DE 69301644T DE 69301644 D1 DE69301644 D1 DE 69301644D1
Authority
DE
Germany
Prior art keywords
alkoxy
alkyl
hydrogen
optionally substituted
serotonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69301644T
Other languages
English (en)
Other versions
DE69301644T2 (de
Inventor
John Fairhurst
David Edward Tupper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of DE69301644D1 publication Critical patent/DE69301644D1/de
Publication of DE69301644T2 publication Critical patent/DE69301644T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/38—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with the sulfur atom of the thio group bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/66—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems and singly-bound oxygen atoms, bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
DE69301644T 1992-08-26 1993-08-25 1-Alkoxy-naphtalen-2-carboxamid-Derivate mit hoher Affinität für das 5-HT1A Rezeptor von Serotonin Expired - Fee Related DE69301644T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929218113A GB9218113D0 (en) 1992-08-26 1992-08-26 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
DE69301644D1 true DE69301644D1 (de) 1996-04-04
DE69301644T2 DE69301644T2 (de) 1996-07-11

Family

ID=10720969

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69301644T Expired - Fee Related DE69301644T2 (de) 1992-08-26 1993-08-25 1-Alkoxy-naphtalen-2-carboxamid-Derivate mit hoher Affinität für das 5-HT1A Rezeptor von Serotonin

Country Status (10)

Country Link
US (1) US5389684A (de)
EP (1) EP0585116B1 (de)
JP (1) JPH06184074A (de)
AT (1) ATE134608T1 (de)
CA (1) CA2104626A1 (de)
DE (1) DE69301644T2 (de)
DK (1) DK0585116T3 (de)
ES (1) ES2084454T3 (de)
GB (1) GB9218113D0 (de)
GR (1) GR3019583T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395835A (en) * 1994-03-24 1995-03-07 Warner-Lambert Company Naphthalamides as central nervous system agents
FR2738569B1 (fr) * 1995-09-12 1997-11-28 Pf Medicament Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique
US6348058B1 (en) * 1997-12-12 2002-02-19 Surgical Navigation Technologies, Inc. Image guided spinal surgery guide, system, and method for use thereof
US6410562B1 (en) * 1998-12-18 2002-06-25 Eli Lilly And Company Hypoglycemic imidazoline compounds
US6693134B2 (en) * 2001-05-29 2004-02-17 Chemokine Therapeutics Corporation Bicyclic aromatic chemokine receptor ligands
US20090216645A1 (en) * 2008-02-21 2009-08-27 What's In It For Me.Com Llc System and method for generating leads for the sale of goods and services

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2766173A (en) * 1953-03-12 1956-10-09 Heyden Chemical Corp Alkylamino 2-oxy-3-naphthoamide anesthetic compositions
NL133069C (de) * 1966-07-29
US3838169A (en) * 1968-07-29 1974-09-24 Ile De France 3-alkoxy-thianaphthene-2-carboxamides
MC807A1 (fr) * 1968-07-29 1970-07-30 Soc Et Scient Et Ind De L Ile Procédé de préparation de 3-alcoxy-thianaphtene-carboxamide substituées ou non
US3829467A (en) * 1972-07-03 1974-08-13 Rorer Inc William H Tetrahydronaphthylalkanoic acids and their derivatives
GB1374366A (en) * 1972-07-21 1974-11-20 Science Union & Cie Propanol derivatives and a process for their preparation
US4540814A (en) * 1983-06-24 1985-09-10 Adria Laboratories, Inc. 1,4-Dimethoxy naphthalenecarboxamide anticonvulsants
GB8328757D0 (en) * 1983-10-27 1983-11-30 Wellcome Found Chemical compounds
IL74694A0 (en) * 1984-04-02 1985-06-30 Merck & Co Inc N-alkenyl-3-hydroxybenzo(b)thiophene-2-carboxamide derivatives,their preparation and pharmaceutical compositions containing them
US4782080A (en) * 1985-09-16 1988-11-01 Merck & Co., Inc. N-alkenyl-2-hydroxybenzo(b)thiophene-3-carboxamide derivatives as dual cyclooxygenase and lipoxygenase inhibitors
US4800211A (en) * 1986-08-18 1989-01-24 Merck & Co., Inc. 5-methylthio-3-hydroxybenzo [b]thiophene-2-carboxamide derivatives as cyclooxygenase and lipoxygenase inhibitors
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion

Also Published As

Publication number Publication date
CA2104626A1 (en) 1994-02-27
ATE134608T1 (de) 1996-03-15
US5389684A (en) 1995-02-14
EP0585116A1 (de) 1994-03-02
DK0585116T3 (da) 1996-03-18
EP0585116B1 (de) 1996-02-28
GR3019583T3 (de) 1996-07-31
DE69301644T2 (de) 1996-07-11
GB9218113D0 (en) 1992-10-14
JPH06184074A (ja) 1994-07-05
ES2084454T3 (es) 1996-05-01

Similar Documents

Publication Publication Date Title
ATE124037T1 (de) Pleuromutiline.
DE69021679T2 (de) Verwendung von Bis(3,4-Dialkylbenzyliden)sorbitolacetale und diese enthaltende Zusammensetzungen.
FI906045A (fi) Kvaevehaltiga spirocykliska foereningar.
ATE112285T1 (de) Adenosin-derivate, die eine aktivität gegen bluthochdruck haben.
ATE80617T1 (de) Mittel zur ortsspezifischen alkylierung.
ATE117681T1 (de) Chinolinderivate, ihre herstellung und verwendung.
ATE103592T1 (de) Carbamoylpyrrolidonderivate, ihre verwendung und herstellung.
MX9202844A (es) 1-indolilalquil-4-( alcoxi-pirimidinil) piperazinas y composicion farmaceutica que las contiene.
NO902513L (no) Fremgangsmaate for fremstilling av nye 2,5-diaryltetrahydrofuraner.
NO304833B1 (no) Nye pyrrolokarbazoler
DE3575420D1 (de) 6-sauerstoffhaltige-1,3,4,5-tetrahydrobenz(cd)indole-4-amine.
DE69301644T2 (de) 1-Alkoxy-naphtalen-2-carboxamid-Derivate mit hoher Affinität für das 5-HT1A Rezeptor von Serotonin
ATE201398T1 (de) Propenon-derivate
PT87050A (pt) Process for preparing indane sulfonamides antiarrhythmic agents
DK0543584T3 (da) Benzo(b)thiophen-2-carboxamider til behandling af forstyrrelser i centralnervesystemet
FI903967A0 (fi) Nya imidazolderivat.
MX9304259A (es) Derivados de alquilendiamina.
DE3781044D1 (de) Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung.
ATE99306T1 (de) Antagonisten von leukotrien d4.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee